Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 165,423 | 145,678 | 116,178 | 170,019 | 153,838 |
| Receivables | 76,466 | 81,195 | 85,427 | 72,953 | 84,380 |
| Inventories | 17,146 | 18,815 | 15,963 | 9,643 | 8,760 |
| TOTAL | $262,132 | $250,813 | $223,675 | $255,720 | $249,785 |
| Non-Current Assets | |||||
| PPE Net | 17,746 | 15,156 | 13,145 | 11,854 | 11,579 |
| Intangibles | 352,699 | 369,494 | 386,289 | 29,503 | 33,191 |
| Other Non-Current Assets | 11,266 | 11,407 | 11,684 | 9,225 | 9,423 |
| TOTAL | $381,711 | $396,057 | $411,118 | $50,582 | $54,193 |
| Total Assets | $643,843 | $646,870 | $634,793 | $306,302 | $303,978 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 47,281 | 47,069 | 46,859 | 3,833 | 2,875 |
| Accounts payable and accrued liabilities | 6,491 | 8,182 | 6,139 | 6,247 | 11,981 |
| Accrued Expenses | 187,956 | 196,164 | 190,700 | 191,029 | 185,877 |
| TOTAL | $242,437 | $252,111 | $244,374 | $201,765 | $201,483 |
| Non-Current Liabilities | |||||
| Long Term Debt | 121,967 | 133,862 | 145,711 | 7,667 | 8,625 |
| Other Non-Current Liabilities | 106,753 | 105,130 | 103,645 | 9,438 | 9,612 |
| TOTAL | $228,720 | $238,992 | $249,356 | $17,105 | $18,237 |
| Total Liabilities | $471,157 | $491,103 | $493,730 | $218,870 | $219,720 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 34,582 | 34,526 | 34,336 | 34,051 | 33,527 |
| Common Shares | 35 | 34 | 34 | 34 | 34 |
| Retained earnings | -340,105 | -351,391 | -359,449 | -359,899 | -357,698 |
| TOTAL | $172,686 | $155,767 | $141,063 | $87,432 | $84,258 |
| Total Liabilities And Equity | $643,843 | $646,870 | $634,793 | $306,302 | $303,978 |